Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 12, Issue 4

July-August 2015

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
In Memoriam
President’s Column
Program Genealogies

Ask the Hematologist

Treating Patients with Relapsed/Refractory Hairy Cell Leukemia

Robert J. Kreitman, MD

View Articletitled, Treating Patients with Relapsed/Refractory Hairy Cell Leukemia

Clinical Trials Corner

Pharmacomechanical Catheter-Directed Thrombolysis: An Attractive Option for Prevention of Post-Thrombotic Syndrome?

Adam Cuker, MD, MS

View Articletitled, Pharmacomechanical Catheter-Directed Thrombolysis: An Attractive Option for Prevention of Post-Thrombotic Syndrome?

Do We Need Another HDAC Inhibitor in Multiple Myeloma?

Noopur Raje, MD,Andrew J. Yee, MD

View Articletitled, Do We Need Another HDAC Inhibitor in Multiple Myeloma?

Diffusion

STAT3 as a Common Pathway for Anaplastic Lymphomas: Something to Target in ALK-Negative Types?

Peter W.M. Johnson, MD

View Articletitled, STAT3 as a Common Pathway for Anaplastic Lymphomas: Something to Target in ALK-Negative Types?

Circulating Tumor Specific DNA: A Promising Biomarker in Diffuse Large B-cell Lymphoma

Ann S. LaCasce, MD, MSc

View Articletitled, Circulating Tumor Specific DNA: A Promising Biomarker in Diffuse Large B-cell Lymphoma

Less Autophagy in Myeloid Precursors Boosts Neutrophil Counts

Mark J. Koury, MD

View Articletitled, Less Autophagy in Myeloid Precursors Boosts Neutrophil Counts

New Light on an Old Drug

Elizabeth Raetz, MD

View Articletitled, New Light on an Old Drug

Fresher Blood is Not Necessarily Better Blood

Evelyn Lockhart, MD,Tracy I. George, MD

View Articletitled, Fresher Blood is Not Necessarily Better Blood

Designer Babies?

Jonathan Hoggatt, PhD

View Articletitled, Designer Babies?

A Synthetic Lethal Approach to Treat Acute Myeloid Leukemia in Patients with Isocitrate Dehydrogenase Mutations

Theresa Coetzer, PhD

View Articletitled, A Synthetic Lethal Approach to Treat Acute Myeloid Leukemia in Patients with Isocitrate Dehydrogenase Mutations

Up Close and Personal: Implanted Devices for Chemotherapy Testing of Tumors in Patients

Pamela S. Becker, MD, PhD

View Articletitled, Up Close and Personal: Implanted Devices for Chemotherapy Testing of Tumors in Patients

The Unfiltered Truth: Anticoagulation Alone is Highly Effective, even in Patients with High-risk Pulmonary Embolism

David Garcia, MD

View Articletitled, The Unfiltered Truth: Anticoagulation Alone is Highly Effective, even in Patients with High-risk Pulmonary Embolism

Features

Health-related Smartphone Apps: Status Update for Hem-Onc Practitioners

Robert I. Liem, MD, MS,Sherif M. Badawy, MD,Alexis Thompson, MD, MPH

View Articletitled, Health-related Smartphone Apps: Status Update for Hem-Onc Practitioners

Therapy-Related AML and MDS: Who Really Has It?

F. Owen Hoffman, PhD,John M. Bennett, MD,Robert Peter Gale, MD, PhD, FACP

View Articletitled, Therapy-Related AML and MDS: Who Really Has It?

In Memoriam

Gerald J. Robbins, MD (1951-2015)

Lawrence A. Solberg, Jr., MD, PhD,Steven L. Allen, MD, FACP

View Articletitled, Gerald J. Robbins, MD (1951-2015)

Aaron J. Marcus, MD (1925-2015)

James Marcus,Babette B. Weksler, MD

View Articletitled, Aaron J. Marcus, MD (1925-2015)

President’s Column

ASH as a Global Organization

David A. Williams, MD

View Articletitled, ASH as a Global Organization

Program Genealogies

Program Genealogies: Myeloma at Mayo

S. Vincent Rajkumar, MD,Robert A. Kyle, MD

View Articletitled, Program Genealogies: Myeloma at Mayo

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Treating Patients with Relapsed/Refractory Hairy Cell Leukemia

Clinical Trials Corner

Pharmacomechanical Catheter-Directed Thrombolysis: An Attractive Option for Prevention of Post-Thrombotic Syndrome?

Do We Need Another HDAC Inhibitor in Multiple Myeloma?

Diffusion

STAT3 as a Common Pathway for Anaplastic Lymphomas: Something to Target in ALK-Negative Types?

Circulating Tumor Specific DNA: A Promising Biomarker in Diffuse Large B-cell Lymphoma

Less Autophagy in Myeloid Precursors Boosts Neutrophil Counts

New Light on an Old Drug

Fresher Blood is Not Necessarily Better Blood

Designer Babies?

A Synthetic Lethal Approach to Treat Acute Myeloid Leukemia in Patients with Isocitrate Dehydrogenase Mutations

Up Close and Personal: Implanted Devices for Chemotherapy Testing of Tumors in Patients

The Unfiltered Truth: Anticoagulation Alone is Highly Effective, even in Patients with High-risk Pulmonary Embolism

Features

Health-related Smartphone Apps: Status Update for Hem-Onc Practitioners

Therapy-Related AML and MDS: Who Really Has It?

In Memoriam

Gerald J. Robbins, MD (1951-2015)

Aaron J. Marcus, MD (1925-2015)

President’s Column

ASH as a Global Organization

Program Genealogies

Program Genealogies: Myeloma at Mayo

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

In Memoriam

President’s Column

Program Genealogies

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only